位置:首页 > 蛋白库 > FLS_CITUN
FLS_CITUN
ID   FLS_CITUN               Reviewed;         335 AA.
AC   Q9ZWQ9;
DT   11-JUL-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   03-AUG-2022, entry version 93.
DE   RecName: Full=Flavonol synthase/flavanone 3-hydroxylase;
DE            EC=1.14.11.9 {ECO:0000250|UniProtKB:Q7XZQ6};
DE            EC=1.14.20.6 {ECO:0000250|UniProtKB:Q7XZQ6};
DE   AltName: Full=CitFLS;
DE            Short=FLS;
GN   Name=FLS;
OS   Citrus unshiu (Satsuma mandarin) (Citrus nobilis var. unshiu).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Sapindales; Rutaceae; Aurantioideae; Citrus.
OX   NCBI_TaxID=55188;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Satsuma Mandarin;
RX   PubMed=11903972; DOI=10.1034/j.1399-3054.2002.1140211.x;
RA   Moriguchi T., Kita M., Ogawa K., Tomono Y., Endo T., Omura M.;
RT   "Flavonol synthase gene expression during citrus fruit development.";
RL   Physiol. Plantarum 114:251-258(2002).
RN   [2]
RP   PROTEIN SEQUENCE OF 1-14, CHARACTERIZATION, AND MUTAGENESIS OF GLY-68 AND
RP   GLY-261.
RX   PubMed=12180990; DOI=10.1046/j.1432-1033.2002.03108.x;
RA   Wellmann F., Lukacin R., Moriguchi T., Britsch L., Schiltz E., Matern U.;
RT   "Functional expression and mutational analysis of flavonol synthase from
RT   Citrus unshiu.";
RL   Eur. J. Biochem. 269:4134-4142(2002).
RN   [3]
RP   FUNCTION.
RX   PubMed=12620339; DOI=10.1016/s0031-9422(02)00567-8;
RA   Lukacin R., Wellmann F., Britsch L., Martens S., Matern U.;
RT   "Flavonol synthase from Citrus unshiu is a bifunctional dioxygenase.";
RL   Phytochemistry 62:287-292(2003).
CC   -!- FUNCTION: Catalyzes the formation of flavonols from dihydroflavonols.
CC       It can act on dihydrokaempferol to produce kaempferol, on
CC       dihydroquercetin to produce quercitin and on dihydromyricetin to
CC       produce myricetin (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:12620339}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + a (2R,3R)-dihydroflavonol + O2 = a flavonol +
CC         CO2 + H2O + succinate; Xref=Rhea:RHEA:21088, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:28802, ChEBI:CHEBI:30031, ChEBI:CHEBI:138188;
CC         EC=1.14.20.6; Evidence={ECO:0000250|UniProtKB:Q7XZQ6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + a (2S)-flavan-4-one + O2 = a (2R,3R)-
CC         dihydroflavonol + CO2 + succinate; Xref=Rhea:RHEA:18621,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:138188, ChEBI:CHEBI:140377;
CC         EC=1.14.11.9; Evidence={ECO:0000250|UniProtKB:Q7XZQ6};
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000250};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000250};
CC   -!- COFACTOR:
CC       Name=L-ascorbate; Xref=ChEBI:CHEBI:38290; Evidence={ECO:0000250};
CC       Note=Binds 1 ascorbate molecule per subunit. {ECO:0000250};
CC   -!- PATHWAY: Secondary metabolite biosynthesis; flavonoid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: In the juice sacs/segment epidermis (edible part)
CC       at the early developmental stage.
CC   -!- DEVELOPMENTAL STAGE: Increases in the peel during fruit maturation.
CC   -!- SIMILARITY: Belongs to the iron/ascorbate-dependent oxidoreductase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011796; BAA36554.1; -; mRNA.
DR   AlphaFoldDB; Q9ZWQ9; -.
DR   SMR; Q9ZWQ9; -.
DR   KEGG; ag:BAA36554; -.
DR   BioCyc; MetaCyc:MON-18283; -.
DR   BRENDA; 1.14.20.6; 1428.
DR   UniPathway; UPA00154; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0045431; F:flavonol synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0031418; F:L-ascorbic acid binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0045486; F:naringenin 3-dioxygenase activity; IEA:UniProtKB-EC.
DR   Gene3D; 2.60.120.330; -; 1.
DR   InterPro; IPR026992; DIOX_N.
DR   InterPro; IPR044861; IPNS-like_FE2OG_OXY.
DR   InterPro; IPR027443; IPNS-like_sf.
DR   InterPro; IPR005123; Oxoglu/Fe-dep_dioxygenase.
DR   Pfam; PF03171; 2OG-FeII_Oxy; 1.
DR   Pfam; PF14226; DIOX_N; 1.
DR   PROSITE; PS51471; FE2OG_OXY; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Dioxygenase; Direct protein sequencing; Flavonoid biosynthesis;
KW   Iron; Metal-binding; Oxidoreductase; Vitamin C.
FT   CHAIN           1..335
FT                   /note="Flavonol synthase/flavanone 3-hydroxylase"
FT                   /id="PRO_0000067292"
FT   DOMAIN          196..296
FT                   /note="Fe2OG dioxygenase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         221
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         223
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   BINDING         277
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00805"
FT   MUTAGEN         68
FT                   /note="G->A: Reduces activity 95%."
FT                   /evidence="ECO:0000269|PubMed:12180990"
FT   MUTAGEN         68
FT                   /note="G->P: Results in complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:12180990"
FT   MUTAGEN         207
FT                   /note="P->G: No effect."
FT   MUTAGEN         261
FT                   /note="G->A: Reduces activity 95%."
FT                   /evidence="ECO:0000269|PubMed:12180990"
FT   MUTAGEN         261
FT                   /note="G->P: Results in complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:12180990"
SQ   SEQUENCE   335 AA;  37899 MW;  157E1AFA4C47564B CRC64;
     MEVERVQAIA SLSHSNGTIP AEFIRPEKEQ PASTTYHGPA PEIPTIDLDD PVQDRLVRSI
     AEASREWGIF QVTNHGIPSD LICKLQAVGK EFFELPQEEK EVYSRPADAK DVQGYGTKLQ
     KEVEGKKSWV DHLFHRVWPP SSINYRFWPK NPPSYRAVNE EYAKYMREVV DKLFTYLSLG
     LGVEGGVLKE AAGGDDIEYM LKINYYPPCP RPDLALGVVA HTDLSALTVL VPNEVPGLQV
     FKDDRWIDAK YIPNALVIHI GDQIEILSNG KYKAVLHRTT VNKDKTRMSW PVFLEPPADT
     VVGPLPQLVD DENPPKYKAK KFKDYSYCKL NKLPQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024